Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Standard BioTools Inc.

    NASDAQ: LAB · Real-Time Price · USD
    1.10
    0.05 (4.76%)
    At close: Jun 16, 2025, 3:59 PM
    1.10
    -0.13%
    After-hours: Jun 16, 2025, 05:15 PM EDT

    Standard BioTools Statistics

    Share Statistics

    Standard BioTools has 379.82M shares outstanding. The number of shares has increased by 0.5% in one year.

    Shares Outstanding

    n/a
    		 379.82M

    Shares Change (YoY)

    n/a
    		 0.5%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 74.92%

    Shares Floating

    n/a
    		 365.93M

    Failed to Deliver (FTD) Shares

    n/a
    		 326

    FTD / Avg. Volume

    n/a
    		 0.03%

    Short Selling Information

    The latest short interest is 17.04M, so 4.72% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 17.04M

    Short % of Shares Out

    n/a
    		 4.72%

    Short % of Float

    n/a
    		 7.65%

    Short Ratio (days to cover)

    n/a
    		 10.63

    Valuation Ratios

    The PE ratio is -4.45 and the forward PE ratio is -7.03. Standard BioTools's PEG ratio is 0.1.

    PE Ratio

    n/a
    		 -4.45

    Forward PE

    n/a
    		 -7.03

    PS Ratio

    n/a
    		 3.54

    Forward PS

    n/a
    		 1.8

    PB Ratio

    n/a
    		 1.31

    P/FCF Ratio

    n/a
    		 -4.07

    PEG Ratio

    n/a
    		 0.1
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Standard BioTools.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.7, with a Debt / Equity ratio of 0.07.

    Current Ratio

    n/a
    		 5.7

    Quick Ratio

    n/a
    		 5.09

    Debt / Equity

    n/a
    		 0.07

    Debt / EBITDA

    n/a
    		 -0.28

    Debt / FCF

    n/a
    		 -0.22

    Interest Coverage

    n/a
    		 -52.85

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $214,289.93

    Profits Per Employee

    n/a
    		 $-170,620.39

    Employee Count

    n/a
    		 814

    Asset Turnover

    n/a
    		 0.28

    Inventory Turnover

    n/a
    		 2.21

    Taxes

    Income Tax

    n/a
    		 573K

    Effective Tax Rate

    n/a
    		 -0.41%

    Stock Price Statistics

    The stock price has increased by -47.87% in the last 52 weeks. The beta is 1.5, so Standard BioTools's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.5

    52-Week Price Change

    n/a
    		 -47.87%

    50-Day Moving Average

    n/a
    		 1.1

    200-Day Moving Average

    n/a
    		 1.54

    Relative Strength Index (RSI)

    n/a
    		 53.15

    Average Volume (20 Days)

    n/a
    		 1,288,736

    Income Statement

    In the last 12 months, Standard BioTools had revenue of 174.43M and earned -138.88M in profits. Earnings per share was -0.52.

    Revenue

    n/a
    		 174.43M

    Gross Profit

    n/a
    		 84.26M

    Operating Income

    n/a
    		 -175.24M

    Net Income

    n/a
    		 -138.88M

    EBITDA

    n/a
    		 -118.14M

    EBIT

    n/a
    		 -135M

    Earnings Per Share (EPS)

    n/a
    		 -0.52
    Full Income Statement

    Balance Sheet

    The company has 166.73M in cash and 33M in debt, giving a net cash position of 133.73M.

    Cash & Cash Equivalents

    n/a
    		 166.73M

    Total Debt

    n/a
    		 33M

    Net Cash

    n/a
    		 133.73M

    Retained Earnings

    n/a
    		 -1.19B

    Total Assets

    n/a
    		 579.6M

    Working Capital

    n/a
    		 287.78M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -143.45M and capital expenditures -8.36M, giving a free cash flow of -151.81M.

    Operating Cash Flow

    n/a
    		 -143.45M

    Capital Expenditures

    n/a
    		 -8.36M

    Free Cash Flow

    n/a
    		 -151.81M

    FCF Per Share

    n/a
    		 -0.43
    Full Cash Flow Statement

    Margins

    Gross margin is 48.31%, with operating and profit margins of -100.46% and -79.62%.

    Gross Margin

    n/a
    		 48.31%

    Operating Margin

    n/a
    		 -100.46%

    Pretax Margin

    n/a
    		 -79.29%

    Profit Margin

    n/a
    		 -79.62%

    EBITDA Margin

    n/a
    		 -67.73%

    EBIT Margin

    n/a
    		 -100.46%

    FCF Margin

    n/a
    		 -87.03%

    Dividends & Yields

    LAB does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for LAB is $2.5, which is 127.3% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $2.5

    Price Target Difference

    n/a
    		 127.3%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -0.82

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist